David Bell, M.D.
Endocrinology, Diabetes & Metabolism Physician in Irondale, Alabama.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
David Bell, M.D. filed 755 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Irondale, Alabama, prescribing 55% generic.
- 755
- Part D claims, 2023
- 55%
- generic prescribing
- $180.03
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
David Bell, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
755 Top 29% higher than 71% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
David Bell, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Bell, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Alabama
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Alabama providers
Endocrinology, Diabetes & Metabolism Physician ranks #86 among Alabama's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Alabama provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
David Bell, M.D. appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 1900 CRESTWOOD BLVD, Irondale, AL, 35210, with a listed phone of (205) 957-0034. NPI 1730230988 was issued on 01/15/2007.
Medicare Part D records for calendar year 2023 show 755 prescription claims written by this provider, covering 43 Medicare beneficiaries and totaling roughly $399K in drug spend, split 42% brand-name and 55% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1730230988 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/15/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm David Bell, M.D.'s current license status, disciplinary history, and board certifications with the Alabama Board of Medical Examiners in Alabama before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1730230988 is the unique 10-digit identifier CMS uses to link Bell across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Bell, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$180
Largest payer
Averitas Pharma Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
42% brand-name claims vs 55% generic, on 755 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,700
- Total Day Supply
- 50,500
- Brand vs Generic
- 42% brand / 55% generic
- Brand Drug Cost
- $353K
- Generic Drug Cost
- $36K
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 40% female / 60% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What David Bell, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ozempic
Ozempic
77 claims
- Jardiance
Jardiance
38 claims
- Spironolactone
Spironolactone
33 claims
- Pioglitazone Hcl 30
Pioglitazone Hcl
30 claims
- Atorvastatin Calcium 29
Atorvastatin Calcium
29 claims
- Metformin Hcl 29
Metformin Hcl
29 claims
- Tresiba Flextouch … 26
Tresiba Flextouch U-100
26 claims
- Rosuvastatin Calcium 25
Rosuvastatin Calcium
25 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 77 |
| Jardiance Empagliflozin | 38 |
| Spironolactone | 33 |
| Pioglitazone Hcl | 30 |
| Atorvastatin Calcium | 29 |
| Metformin Hcl | 29 |
| Tresiba Flextouch U-100 Insulin Degludec | 26 |
| Rosuvastatin Calcium | 25 |
| Icosapent Ethyl | 24 |
| Glimepiride | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How David Bell, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
David Bell, M.D.'s 755 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Bell.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Alabama medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Alabama
Frequently Asked Questions
What is David Bell, M.D.'s specialty? ▼
How much does David Bell, M.D. prescribe under Medicare Part D? ▼
Where is David Bell, M.D. located? ▼
What is David Bell, M.D.'s NPI number? ▼
Does David Bell, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does David Bell, M.D. prescribe most often? ▼
Does David Bell, M.D. accept Medicare? ▼
How can I verify David Bell, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.